Literature DB >> 16382460

National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).

Benjamin L Shneider1, Frederick J Suchy, Sukru Emre.   

Abstract

Since February 2002, the Pediatric End Stage Liver Disease (PELD) scoring system has been utilized as a means of prioritizing children for liver transplantation. The United Network for Organ Sharing database was queried to assess utilization of PELD in 2003 and 2004; 682 liver transplants were performed in pediatric recipients where the PELD score was potentially the primary determinant of liver allocation. In the majority of circumstances (53%) the actual calculated PELD score was not utilized to determine liver allocation. An exception to the PELD score was utilized in 24% of cases. An additional 29% of the children were listed as urgent (status 1) without having acute liver failure. There was considerable regional variability in the inability to utilize actual PELD scores for liver allocation to children. PELD utilization was higher in regions of the country where pediatric donor organs were more available, presumably because children have some priority for organs from pediatric donors. There were 87 deaths in children awaiting liver transplantation. The mean PELD score in children without acute liver failure or metabolic liver disease (n = 33) near the time of death was 24.2, which has a purported 3-month risk of mortality of less than 10%. In our opinion the assigned 3-month risk of mortality associated with PELD scores is understated. Three-month mortality risk is used to inter-convert the adult and pediatric scoring systems. Therefore exceptions to the scoring system are required when children compete with adults for donor organs. In conclusion, urgent reassessment of the PELD scoring system is needed to avoid morbidity and mortality in children. Copyright 2005 AASLD

Entities:  

Mesh:

Year:  2006        PMID: 16382460     DOI: 10.1002/lt.20662

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

1.  Justifying Nonstandard Exception Requests for Pediatric Liver Transplant Candidates: An Analysis of Narratives Submitted to the United Network for Organ Sharing, 2009-2014.

Authors:  E R Perito; H J Braun; J L Dodge; S Rhee; J P Roberts
Journal:  Am J Transplant       Date:  2017-02-28       Impact factor: 8.086

2.  Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation.

Authors:  Douglas B Mogul; Xun Luo; Eric K Chow; Allan B Massie; Tanjala S Purnell; Kathleen B Schwarz; Andrew M Cameron; John F P Bridges; Dorry L Segev
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-03       Impact factor: 2.839

Review 3.  Biliary atresia: Indications and timing of liver transplantation and optimization of pretransplant care.

Authors:  Shikha S Sundaram; Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Liver Transpl       Date:  2017-01       Impact factor: 5.799

4.  Accuracy of the Pediatric End-stage Liver Disease Score in Estimating Pretransplant Mortality Among Pediatric Liver Transplant Candidates.

Authors:  Chung-Chou H Chang; Cindy L Bryce; Benjamin L Shneider; Jonathan G Yabes; Yi Ren; Gabriel L Zenarosa; Heather Tomko; Drew M Donnell; Robert H Squires; Mark S Roberts
Journal:  JAMA Pediatr       Date:  2018-11-01       Impact factor: 16.193

5.  Nonstandard Exception Requests Impact Outcomes for Pediatric Liver Transplant Candidates.

Authors:  H J Braun; E R Perito; J L Dodge; S Rhee; J P Roberts
Journal:  Am J Transplant       Date:  2016-06-27       Impact factor: 8.086

6.  Random forest analysis identifies change in serum creatinine and listing status as the most predictive variables of an outcome for young children on liver transplant waitlist.

Authors:  Sakil Kulkarni; Lisa Chi; Charles Goss; Qinghua Lian; Michelle Nadler; Janis Stoll; Maria Doyle; Yumirle Turmelle; Adeel Khan
Journal:  Pediatr Transplant       Date:  2020-11-24

Review 7.  Global lessons in graft type and pediatric liver allocation: A path toward improving outcomes and eliminating wait-list mortality.

Authors:  Evelyn K Hsu; George V Mazariegos
Journal:  Liver Transpl       Date:  2017-01       Impact factor: 5.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.